Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMade Tech Regulatory News (MTEC)

Share Price Information for Made Tech (MTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 13.00
Ask: 14.00
Change: 0.25 (1.89%)
Spread: 1.00 (7.692%)
Open: 13.25
High: 13.50
Low: 13.25
Prev. Close: 13.25
MTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Aug 2022 07:00

RNS Number : 5339W
Made Tech Group PLC
19 August 2022
 

 19 August 2022

MADE TECH GROUP PLC

("Made Tech" or the "Group")

 

TRADING UPDATE

Strong accelerating growth in FY22 with significant opportunities ahead

 

Made Tech Group plc, a leading provider of digital, data and technology services to the UK public sector, is pleased to announce the following trading update ahead of its Audited Final Results for the year ended 31 May 2022 ("FY22" or the "Period"), which are scheduled to be released in September.

 

Highlights*

 

Revenue of £29.3m (FY21: £13.3m) - up 120%

Gross profit margin maintained at 38% (FY21: 38%)

Adjusted EBITDA1 of £2.6m (FY21: loss of £0.5m) - up 618%

Cash at 31 May 2022 of £12.3m (FY21: £0.9m)

Sales Bookings2 in FY22 totalling £51.1m (FY21: £23.8m) - up 115%

Contracted backlog3 at £38.2m (FY21: £16.4m) - up 133%

Headcount of 478 (414 permanent employees and 64 contractors) at 31 May 2022 (31 May 2021: 235) - recruitment target achieved despite increased demand and competition for talent

 

1

Adjusted EBITDA excludes exceptional costs of £0.2m and share based payment charges of £2.4m

2

 Sales bookings represent the total value of sales contracts awarded in the year, to be delivered in FY22-FY25

3

Contracted Backlog is the value of contracted revenue that has yet to be recognised

*

Subject to audit

 

The Group delivered substantial organic growth from its long-term client relationships in the Period, as well as continuing to broaden its client base with new client wins across Central Government, Local Government, Health and Devolved Administrations. This included a first major two-year contract with NHS Digital, worth approximately £19m to the Group. The strong level of client acquisition achieved in FY22 has continued into the new financial year, as demonstrated by the recently announced contract with the Met Office, valued at not less than £7m over a two-year period. 

 

Made Tech is a people business, operating in a fast-growing market, and talent acquisition is essential to the Group's successful growth. Recruitment accelerated in H2 in line with our strategy, despite the continuing macro challenges, with headcount increasing by over 100% year on year.

Broadening capability and geographic coverage are key to Made Tech's strategy to diversify revenue and deliver further organic growth. To support its growth, the Group expanded its service offering to include new capabilities in Data and Cyber and continued to increase headcount in User Centred Design. The geographic coverage of the business was also extended during the year with the first Made Tech employees being hired in Scotland, Newcastle and the Midlands. 

 

Following an internal review, the Board is pleased to announce the appointment of Singer Capital Markets as sole broker and nominated adviser to the Group and Belvedere Communications as financial PR adviser.

 

Outlook

 

With a robust balance sheet and strong levels of client acquisition and talent recruitment, enabling the fulfilment of the contracted backlog, Made Tech is well positioned to capitalise on the substantial and continuing growth of the digital transformation market. Our robust pipeline and record sales bookings underpin the Board's confidence in the prospects for the business for the current financial year ("FY23") and beyond.

 

Rory MacDonald, CEO of Made Tech, said: 

 

"FY22 was a very significant year for Made Tech, one in which we delivered exceptionally high levels of organic growth. We navigated the well-documented macro recruitment challenges to double our headcount year on year and maintain our gross margin. We have made a strong start to FY23 and look forward to updating our stakeholders on the Group's progress, when we announce the FY22 results in September."

 

Enquiries:

 

Made Tech

Rory MacDonald, CEO

Deborah Lovegrove, CFO

 

via Belvedere PR

Singer Capital Markets (Nominated Adviser & Broker)

Mark Taylor / Jen Boorer / Harry Gooden / Asha Chotai

 

Tel: +44 (0) 20 7496 3000

 

Belvedere PR (Financial PR)

Cat Valentine 

Keeley Clarke 

Email:  madetech@belvederepr.com

Tel: +44 (0) 7715 769078

Tel: +44 (0) 7967 816525

 

About Made Tech

 

Made Tech is a high-growth provider of digital, data and technology services to the UK public sector. Founded in 2008 and with a headcount of over 470 across multiple UK locations, Made Tech provides services that enable central government, healthcare and local government organisations to digitally transform.

 

The Group's purpose is to "positively impact the future of society by improving public sector technology". To achieve this the Group has four key strategic missions: Modernise legacy technology and working practices; Accelerate digital service and technology delivery; Drive better decisions through data and automation; and Enable technology and delivery skills to build better systems. 

 

More information is available at www.madetech.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFUFMAEESELA
12
Date   Source Headline
23rd Apr 20243:47 pmRNSTR-1
22nd Apr 20247:00 amRNSMade Tech awarded £19.5m new contract with DLUHC
29th Feb 20247:00 amRNSTR-1
26th Feb 20249:09 amRNSHalf Year Results
26th Feb 20247:00 amRNSHalf Year Results
1st Feb 20247:00 amRNSTrading Update and Notice of Results
9th Jan 20247:00 amRNSAppointment of new CFO and Board Changes
17th Nov 20232:48 pmRNSDirector Share Purchase
30th Oct 20237:00 amRNSExercise of options and PDMR Dealing
26th Oct 20231:33 pmRNSResult of AGM
20th Sep 20233:55 pmRNSNotice of AGM and Posting of Annual Report 2023
13th Sep 20237:00 amRNSAudited Final Results 2023
6th Sep 20237:00 amRNSNotice of Results and Online Presentations
16th Aug 20235:26 pmRNSTR-1
25th Jul 20232:43 pmRNSGrant of LTIP Awards
5th Jul 20237:00 amRNSDirector Share Purchase
19th Jun 202310:03 amRNSTR-1
26th May 202312:38 pmRNSHolding(s) in Company
5th May 202312:56 pmRNSTR-1
2nd May 20237:00 amRNSTrading Update
17th Apr 20237:12 amRNSTR1
23rd Feb 20237:05 amRNSLTIP Update and PDMR Dealing
23rd Feb 20237:00 amRNSHalf Year Results
2nd Feb 202311:05 amRNSSecond Price Monitoring Extn
2nd Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20232:05 pmRNSSecond Price Monitoring Extn
1st Feb 20232:00 pmRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSTrading Update and Notice of Results
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
15th Nov 202211:05 amRNSSecond Price Monitoring Extn
15th Nov 202211:00 amRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSNew £10m contract with the Home Office
19th Oct 20225:17 pmRNSResult of AGM, Deferred Shares & Issue of Equity
29th Sep 20227:00 amRNSIssue of New Ordinary Shares to EBT
23rd Sep 20224:31 pmRNSNotice of AGM and Posting of Annual Report 2022
12th Sep 20227:00 amRNSAudited Final Results
26th Aug 20229:00 amRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSNotice of Final Results and Online Presentations
19th Aug 20227:00 amRNSTrading Update
1st Jul 20227:00 amRNSMet Office Contract
24th Jun 20224:41 pmRNSSecond Price Monitoring Extn
24th Jun 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
2nd Mar 202210:56 amRNSDirector Share Purchase
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.